综合性癌症中心
美国顶尖的癌症中心之一
The UCLA Health 约翰逊综合癌症中心 has been designated a "comprehensive cancer center" by the National Cancer Institute, 证明了它在癌症研究方面的卓越成就, 教育, and community outreach and through its strong partnership with UCLA Health to providing outstanding cancer patient care, 预防和生存.
皇冠hga025大学洛杉矶分校健康中心, 专家团队合作治疗和帮助癌症患者及其家属. This multidisciplinary approach helps patients and family members confront both the immediate and long-term effects of cancer. 作为nci指定的癌症中心, we are actively working to reduce or eliminate current disparities in the burden of cancer and to ensure that all Americans share equally in the medical advances that result from cancer research.
连续24年, the UCLA Health 约翰逊综合癌症中心 has been recognized as one of the best locations in the country to receive cancer care on the U.S. 皇冠hga025 & 世界报道 全国光荣榜. 2023年 U.S. 皇冠hga025 best hospital specialty rankings named the UCLA Health 约翰逊综合癌症中心 No. 在皇冠hga025和洛杉矶大都会区均排名第一. 4在医院癌症治疗的国家.
最先进的癌症治疗方法
The UCLA Health 约翰逊综合癌症中心 has established an international reputation for developing new cancer therapies, 提供最好的实验和传统治疗方法. UCLA conducts research for a wide range of cancers and offers patients the opportunity to participate in clinical trials and research. 我们结束了 400项正在进行的临床试验 专注于癌症治疗目前正在皇冠hga025大学洛杉矶分校招收患者, and offer clinical trials not only in Los Angeles but at partner institutions across the country.
发现癌症预防方面的突破 & 治疗
有500多名医生和科学家, the UCLA Health 约翰逊综合癌症中心 is one of the largest comprehensive cancer centers in the nation. With an international reputation for providing the best in experimental and traditional cancer 治疗s, 我们的专家指导下一代医学研究人员. 成功的靶向治疗，如赫赛汀, 格列卫, and Sprycel were 发达 based on basic science performed in UCLA laboratories and clinical trials with UCLA patients.
历史 & 任务
在60年代末, a group of scientists and volunteers at UCLA came together to develop a cancer center they hoped would become renowned for excellence in research, 教育和病人护理. 从那时起, the UCLA Health 约翰逊综合癌症中心 has become a leader in cancer research and clinical care with a vision of accelerating discoveries to prevent and cure cancer.
今天，皇冠hga025大学洛杉矶分校健康约翰逊综合癌症中心就是其中之一 只有56个综合癌症中心 是国家癌症研究所(NCI)的最高级别. The NCI recognizes centers around the country that meet rigorous standards for transdisciplinary, 最先进的研究侧重于开发新的和更好的预防方法, 诊断, 治疗癌症. 自1976年以来，癌症中心一直享有这一称号.
为什么选择我们的癌症中心?
该领域的领导者
我们有超过 500名科学家和医生 who conduct basic and translational cancer research and provide comprehensive cancer care
改变治疗
自2014年以来, research at the UCLA Health 约翰逊综合癌症中心 has led or contributed to 22日批准 从FDA获得新的癌症治疗或方案，这是一个了不起的成就.
数十年的经验
The UCLA Health 约翰逊综合癌症中心 has held the highest designation possible from the National Cancer Institute (NCI) since 1976.
Dr. 丹尼斯Slamon discovered the relationship between the HER-2/neu gene and an aggressive form of breast cancer found in about 30 percent of patients. 这一发现导致了新型乳腺癌药物的开发 赫赛汀, FDA于9月25日批准, 1998, 使其成为首个被批准的从基因根源攻击癌症的治疗方法.
开发的 Dr. 安东尼里巴斯, Keytruda 9月14日FDA批准了首个免疫疗法吗, 2014年治疗晚期黑色素瘤. 这标志着致命皮肤癌治疗方式的范式转变, the research was conducted at UCLA and 11 other sites across the world as part of the largest phase 1 clinical study in the history of oncology.
根据里巴斯的研究， Dr. 爱德华Garon 领导了迄今为止发表的使用免疫疗法治疗肺癌的最大研究. 它于10月2日获得了FDA的批准, 2015年，Keytruda用于晚期非小细胞肺癌. 2014年10月，FDA授予该药“突破性疗法”地位, 允许它快速获得批准.
In 2014, 加隆也是一项多年研究的首席研究员, 的国际三期临床试验 Cyramza. 测试在1个以上,200名患者, the drug was found to extend survival significantly in NSCLC and approved by the FDA on December 12, 2014.
Slamon和 Dr. 理查德·芬恩 发达 IBRANCE, a groundbreaking new 治疗 strategy to arrest tumor growth in women with estrogen-receptor positive advanced breast cancer. 2015年2月3日获FDA批准.
转化研究进展
肉瘤
Dr. 弗雷德Eilber 开发了一种残肢抢救技术，现已成为全国样板. 他在手术前对肉瘤患者进行化疗, 避免了截肢，否则就需要截肢.
卵巢癌
Dr. Mark Pegram led the team of Jonsson 癌症中心 doctors who were the first to treat ovarian cancer patients with gene therapy using the p53 tumor suppressor gene.
肾癌
Drs. Robert Figlin and Arie Belldegrun 发达 a new approach to treating metastatic kidney cancer by combining biologic and cellular therapies to extend re任务 times.
病人恢复
Dr. Judith Gasson及其同事纯化了GM-CSF, which shortened the time it takes for cancer patients to recover their white blood cell counts (from five to two weeks) after bone marrow transplants.
BMT
Dr. 约翰-格兰斯潘说 博士和. Mary Territo used megakaryocyte growth and development factor (MGDF) for the first time to speed up a cancer patient´s bone marrow recovery after transplant.
饮食和营养
Glaspy demonstrated for the first time that dietary regulation of certain fatty acids can change the composition of human breast tissue in such a way that it may be more resistant to cancer.
乳腺癌
In 1992, UCLA Health opened the first multidisciplinary breast cancer center on the West Coast, the 露华浓/UCLA乳房中心对于有乳房问题或患乳腺癌风险高的女性来说，这是一项非常重要的建议.
前列腺癌
Dr. 查尔斯·索耶斯发明了第一个前列腺癌动物模型, and the ability to grow those cells in animals provided researchers with a crucial new research tool.
